Fear and addiction exert significant influence within society. Managing them is often challenging, as they are driven by intricate neuronal circuits in our brains.
Optimi Health Welcomes Dr. Preston A. Chase as New Chief Science Officer | Psychedelic Invest
Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Canadian psychedelics drug research and formulation company, is delighted to announce the appointment of
November 7, 2023